q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

June 2023 Medicare Drug List Updates: Sixty-three (63) medications added to the 2023 Medicare Part D Drug plan formularies.

Category: Monthly Formulary changes
Published: Jun, 19 2023 10:06:49
< Previous
Next >
The June 2023 Medicare Part D prescription drug plan formulary (drug list) data is now online and included in our Formulary Browser and Q1Rx Drug Finder.

The June formulary updates include the addition of 97 new National Drug Codes (NDCs), representing 63 different prescription drugs, many with multiple strengths.

The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).


Highlights of the June 2023 Formulary updates include ten (10) newly-introduced brand-name drugs

The June drug data updates include twenty-four (24) new brand-name drugs, ten (10) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
  • FUROSCIX®,
  • Jaypirca®,
  • KITABIS PAK®,
  • KONVOMEP®,
  • LYTGOBI®,
  • ORSERDU®,
  • REZLIDHIA®,
  • Subvenite®,
  • TYBLUME®, and
  • ZTALMY®.

The June 2023 Formulary updates include fifteen (15) newly-added generic drugs

The June Medicare Part D drug data also includes thirty-nine (39) new generic medications, fifteen (15) of which are newly-introduced generic drugs.  These new generic drugs include:
  • APRACLONIDINE HCL [Iopidine®],
  • DILTIAZEM LA [Cardizem LA®],
  • DOXYCYCLINE IR-DR [Oracea®],
  • LIDOCAINE Viscous [Xylocaine Viscous®],
  • LURASIDONE HCL [Latuda®],
  • METHYLPHENIDATE [RELEXXII®],
  • NALOCET [Primalev®],
  • NEO-POLYCIN EYE OINTMENT [Polymycin®],
  • NEO-POLYCIN HC EYE OINTMENT [Ocu-Cort®],
  • OFLOXACIN [Ocuflox®],
  • POLYCIN EYE OINTMENT [Polytracin®],
  • PREDNISOLONE [Prelone®],
  • CLINDACIN [Evoclin®],
  • TASIMELTEON [HETLIOZ®], and
  • TERIFLUNOMIDE [AUBAGIO®].
You can read more about the new generics in our article: June 2023 Drug List Updates: Fifteen (15) new generic drugs added to many Medicare Part D plan formularies.

Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.

Reminders about Medicare prescription drug plan formulary changes
  1. Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.

  2. In most cases, your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

Good to know: What is the NDC?

The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: Q1FAQ.com/155


Summary of June 2023 NDC changes

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 97 new June 2023 NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 4
New Delivery Form and Strength 6
New Drug 29
New Drug and Strength 34
New Manufacturer and Strength 4
New Manufacturer, Strength and Delivery Form 4
New Strength 16
Grand Total 97

The following chart details the 97 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.

You can click on the Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state).  You can then change the state in our search form for details of drug coverage in your service area.


NDC Drug Name Number of
PDP Formularies*		 Number of
MAPD Formularies*		 Notes
72143025430 ACCUTANE 40 MG CAPSULE [ZENATANE] 52 355 New Strength
00121050416 ACETAMINOP-CODEINE 120-12 MG/5 SOLUTION 62 383 New Drug
52817081615 ACETIC ACID 2% EAR SOLUTION [VoSoL] 62 387 New Drug
16571088409 ALLOPURINOL 200 MG TABLET 0 6 New Drug
61314066505 APRACLONIDINE HCL 0.5% DROPS [Iopidine] 28 261 New Drug
45802081696 CALCIPOTRIENE-BETAMETH DP OINTMENT [Taclonex] 1 36 New Drug
00049271610 CARDURA 8 MG TABLET 1 2 New Strength
43538017910 CLINDACIN 1% FOAM [Evoclin] 4 32 New Drug
70436019604 DILTIAZEM 24H ER (LA) 180 MG TABLET [Matzim LA] 42 222 New Drug and Strength
70436019704 DILTIAZEM 24H ER (LA) 240 MG TABLET [Matzim LA] 42 222 New Drug and Strength
70436019804 DILTIAZEM 24H ER (LA) 300 MG TABLET [Matzim LA] 42 222 New Drug and Strength
70436019904 DILTIAZEM 24H ER (LA) 360 MG TABLET [Matzim LA] 42 222 New Drug and Strength
70436020004 DILTIAZEM 24H ER (LA) 420 MG TABLET [Matzim LA] 43 215 New Drug and Strength
70436019504 DILTIAZEM 24H ER (LA) 120 MG TABLET [Cardizem LA] 40 199 New Drug
51862056012 DORYX MPC DR 60 MG TABLET 0 3 New Strength
68308066830 DOXYCYCLINE IR-DR 40 MG CAPSULE [Oracea] 1 19 New Strength
42858086906 DRONABINOL 10 MG CAPSULE [Marinol] 62 391 New Drug and Strength
42858086706 DRONABINOL 2.5 MG CAPSULE [Marinol] 62 391 New Drug and Strength
42858086806 DRONABINOL 5 MG CAPSULE [Marinol] 62 391 New Drug and Strength
62935046150 ELIGARD 45 MG SYRINGE KIT 35 310 New Strength
60951070170 ENDOCET 2.5-325 MG TABLET [Percocet] 62 351 New Drug
59676060430 ERLEADA 240 MG TABLET 62 390 New Strength
66993008796 FLUTICASONE-SALMETEROL 115-21 HFA AER AD [Advair HFA] 0 23 New Drug and Strength
66993008896 FLUTICASONE-SALMETEROL 230-21 HFA AER AD [Advair HFA] 0 23 New Drug and Strength
66993008696 FLUTICASONE-SALMETEROL 45-21 HFA AER AD [Advair HFA] 0 23 New Drug and Strength
71767010001 FUROSCIX 80 MG/10ML ON-BODY KIT 1 47 New Drug
61314063305 GENTAMICIN 0.3% EYE DROPS [Ocu-Mycin] 62 391 New Drug
51672300701 HYDROCORTISON-ACETIC ACID SOLUTION DROPS [VoSoL HC] 48 293 New Drug
42543097025 HYDROCORTISONE 5 MG TABLET [Cortef] 62 391 New Manufacturer and Strength
00002702660 JAYPIRCA 100 MG TABLET 62 391 New Drug and Strength
00002690230 JAYPIRCA 50 MG TABLET 62 391 New Drug and Strength
24492085056 KITABIS PAK 300 MG/5 ML AMPUL-NEB 1 17 New Drug
65628027210 KONVOMEP 2-84 MG/ML ORAL SUSPENSION 0 1 New Drug
49884088099 LAMOTRIGINE ODT KIT (BLUE) TB RD DSPK [Lamictal ODT] 9 126 New Strength
49884088199 LAMOTRIGINE ODT KIT (GREEN) TB RD DSPK [Lamictal ODT] 9 124 New Strength
60432046400 LIDOCAINE 2% VISCOUS SOLUTION [Xylocaine Viscous] 60 389 New Drug
00574204230 LIDOCAINE-PRILOCAINE CREAM (G) [SOLUPICC] 62 389 New Drug
31722086525 LINEZOLID 100 MG/5 ML ORAL SUSPENSION [Zyvox Powder] 62 375 New Manufacturer, Strength and Delivery Form
16729035010 LURASIDONE HCL 120 MG TABLET [Latuda] 59 387 New Drug and Strength
16729034610 LURASIDONE HCL 20 MG TABLET [Latuda] 59 387 New Drug and Strength
16729034710 LURASIDONE HCL 40 MG TABLET [Latuda] 59 387 New Drug and Strength
16729034810 LURASIDONE HCL 60 MG TABLET [Latuda] 59 387 New Drug and Strength
16729034910 LURASIDONE HCL 80 MG TABLET [Latuda] 59 387 New Drug and Strength
64842012004 LYTGOBI 12 MG DOSE (3X 4MG TB) TABLET 62 391 New Drug and Strength
64842012005 LYTGOBI 16 MG DOSE (4X 4MG TB) TABLET 62 391 New Drug and Strength
64842012006 LYTGOBI 20 MG DOSE (5X 4MG TB) TABLET 62 391 New Drug and Strength
00078079205 MAXITROL EYE DROPS EYE DROPPER 0 2 New Delivery Form and Strength
68382054706 MEMANTINE HCL ER 14 MG CAPSULE SPR 24 [Namenda XR] 50 369 New Strength
68382054806 MEMANTINE HCL ER 21 MG CAPSULE SPR 24 [Namenda XR] 50 369 New Strength
68382054606 MEMANTINE HCL ER 7 MG CAPSULE SPR 24 [Namenda XR] 50 371 New Strength
13811071130 METHYLPHENIDATE ER 45 MG TABLET ER 24 [RELEXXII] 0 21 New Drug and Strength
13811070030 METHYLPHENIDATE ER 63 MG TABLET ER 24 [RELEXXII] 0 21 New Drug and Strength
72245019310 NALOCET 2.5-300 MG TABLET [Primalev] 0 2 New Drug
00093216568 NALOXONE HCL 4 MG NASAL SPRAY [Narcan] 60 387 New Manufacturer, Strength and Delivery Form
00574425035 NEO-POLYCIN EYE OINTMENT [Polymycin] 57 338 New Drug
00574414435 NEO-POLYCIN HC EYE OINTMENT [Ocu-Cort] 53 326 New Drug
24208043405 OFLOXACIN 0.3% EYE DROPS [Ocuflox] 61 391 New Drug
72187010203 ORSERDU 345 MG TABLET 62 390 New Drug and Strength
72187010103 ORSERDU 86 MG TABLET 62 390 New Drug and Strength
00574402135 POLYCIN EYE OINTMENT [Polytracin] 58 327 New Drug
69238145802 POTASSIUM CL 20% (40 MEQ/15ML) LIQUID [Kaon-CL] 59 386 New Drug
69238145902 POTASSIUM CL 10% (20 MEQ/15ML) LIQUID [Kay Ciel] 62 391 New Drug
00597044587 PRADAXA 110 MG PELLET PACK 0 6 New Delivery Form
00597045016 PRADAXA 150 MG PELLET PACK 0 6 New Delivery Form
00597042578 PRADAXA 20 MG PELLET PACK 0 6 New Delivery Form and Strength
00597043018 PRADAXA 30 MG PELLET PACK 0 6 New Delivery Form and Strength
00597043596 PRADAXA 40 MG PELLET PACK 0 6 New Delivery Form and Strength
00597044053 PRADAXA 50 MG PELLET PACK 0 6 New Delivery Form and Strength
62135025047 PREDNISOLONE 15 MG/5 ML SOLUTION [Prelone] 62 391 New Drug
72245064850 PROLATE 10 MG-300 MG/5 ML SOLUTION 0 4 New Delivery Form
70954048430 PYRAZINAMIDE 500 MG TABLET 62 391 New Drug
68025008830 RELEXXII ER 45 MG TABLET ER 24 0 7 New Strength
68025008930 RELEXXII ER 63 MG TABLET ER 24 0 7 New Strength
71332000501 REZLIDHIA 150 MG CAPSULE 62 391 New Drug
16571080901 SEROQUEL 150 MG TABLET 54 312 New Manufacturer and Strength
61958150301 SOVALDI 200 MG TABLET 18 40 New Delivery Form
69102031901 SUBVENITE 100 MG TABLET 60 323 New Drug and Strength
69102015006 SUBVENITE 150 MG TABLET 60 323 New Drug and Strength
69102032001 SUBVENITE 200 MG TABLET 60 323 New Drug and Strength
69102030101 SUBVENITE 25 MG TABLET 60 323 New Drug and Strength
69102030001 SUBVENITE TABLET START KIT(ORANGE) TABLET DS PK 14 94 New Drug and Strength
69102031201 SUBVENITE TABLET START KIT (GREEN) TABLET DS PK 14 94 New Drug and Strength
69102030601 SUBVENITE TABLET START KIT (BLUE) TABLET DS PK 15 94 New Drug and Strength
27437020808 SUPRAX 400 MG CAPSULE 4 23 New Delivery Form and Strength
47783064501 TAKHZYRO 150 MG/ML SYRINGE 1 118 New Strength
70709006230 TASCENSO ODT 0.25 MG TABLET RAPDIS 1 65 New Strength
00480449056 TASIMELTEON 20 MG CAPSULE [HETLIOZ] 52 328 New Drug
43547061303 TEMAZEPAM 22.5 MG CAPSULE [Restoril] 4 80 New Manufacturer and Strength
43547061110 TEMAZEPAM 7.5 MG CAPSULE [Restoril] 18 170 New Manufacturer and Strength
00115261101 TERBUTALINE SULFATE 2.5 MG TABLET [Brethine] 47 348 New Strength
31722024730 TERIFLUNOMIDE 14 MG TABLET [AUBAGIO] 16 224 New Drug and Strength
31722024630 TERIFLUNOMIDE 7 MG TABLET [AUBAGIO] 16 224 New Drug and Strength
69918060160 TIMOLOL MALEATE 0.5% EYE DROP DROPERETTE [Timoptic Ocumeter] 4 68 New Manufacturer, Strength and Delivery Form
24208049968 TIMOPTIC 0.5% OCUDOSE DROP DROPERETTE 1 2 New Manufacturer, Strength and Delivery Form
00264193310 TROPHAMINE 10% IV SOLUTION 54 354 New Drug
00642747101 TYBLUME 0.1-0.02 MG CHEWABLE TABLET 16 173 New Drug
81583010005 ZTALMY 50 MG/ML ORAL SUSPENSION 62 391 New Drug




If your brand-name drug is no longer covered by your Medicare Part D plan, you can use the 30-day notice period (if notice is provided) to:
  • Ask your prescriber about trying the generic.

  • Check for an alternative formulary drug.

  • Ask your plan to cover a non-formulary drug. 
    You will need to work with your doctor or prescriber to explain why you are not able to use the generic medication or why no other formulary drug is acceptable.  If your formulary exception is denied, you have the right to appeal your plan’s decision.

  • Consider using a Special Enrollment Period and move to another Medicare plan that provides coverage of all your prescription and health needs.
Learn more in our article: How a mid-year formulary change can affect your Medicare Part D drug coverage.

Our online Formulary Browser and Drug Finder

You can review any Medicare plan formulary using the Q1Medicare.com Formulary Browser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
April 2024, September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
April 2024, September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting your Medicare plan
Star Ratings & plan quality
Annual Medicare plan changes
Enrollment topics
Late Enrollment Penalty (LEP)
Your Formulary (Drug List)
Monthly Formulary changes
Your Medicare plan coverage
Pharmacies & Providers
Changing Medicare plans
Special Enrollment Periods (SEPs)
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and high costs
Out-of-Pocket: TrOOP, RxMOOP, and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for higher incomes
Medicare Advantage plans (MAPD)
Medicare Supplements - Medigap
Medicare plan providers
General Medicare Part D (PDP)
General Medicare
Diabetes and diabetic coverage
Your Health & Wellness
About Q1Medicare.com


Pets are Family Too!
Use your drug discount card to save on medications for the entire family ‐ including your pets.

» Learn more about savings on Pet Medications
  • No enrollment fee and no limits on usage
  • Everyone in your household can use the same card, including your pets
Your drug discount card is available to you at no cost.


© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.